Skip to main content
. 2021 Aug 28;23:107–123. doi: 10.1016/j.omto.2021.08.013

Figure 4.

Figure 4

OA promptly downregulates two key metabolic enzymes in the PSP

(A) Western blot showing the time course of 200 μM OA treatment effects on protein levels of HGPRT and 5′-NT in A549 and MDA-MB-231 cells. (B and C) The influence of oral administration of OA on protein levels of HGPRT and 5′-NT in A549 (B) and MDA-MB-231 (C) tumor xenografts. OA was orally administered to the treatment group at 120 mg/kg/day until the end of the experiment. Twenty-two days after the subcutaneous injection of tumor cells, the tumor xenografts were resected for western blot assay. (D) The impact of individual and simultaneous deletion of HPRT1 and NT5E on A549 cell proliferation. The cells were cultured for 72 h, and viable cells were counted with an ATPlite kit. (E) Individual overexpression of HPRT1 and NT5E in A549 cells opposing proliferation arrest induced by 200 μM OA treatment. The cells were cultured for 72 h, and viable cells were counted by CCK-8. Error bars represent mean ± SEM. ∗∗p < 0.01, ∗∗∗p < 0.001, Student’s t test.